Ranibizumab 0.5mg
You Searched
₹70,160


WHO GMP
Certified

Long Expiry
(>8 Months)

WHO GMP
Certified

Long Expiry
(>8 Months)
In Diabetic eye disease Diabetic eye disease is a group of eye problems seen in people with diabetes. It can lead to vision loss, weak eyesight or even blindness. Lucentis Injection helps prevent this damage caused by diabetes and stops the worsening of vision. Consult your doctor if you have any doubts. In Wet age-related macular degeneration Macula is the part of the retina responsible for central vision. Wet age-related macular degeneration is an eye disorder that causes blurred vision or a blind spot in your visual field due to abnormal blood vessels that leak fluid or blood into the macula. This leads to vision problems. Lucentis Injection helps prevent leakage of such abnormal blood vessels and therefore prevents vision loss. It is given as an injection by a doctor or nurse and should not be self-administered. In Macular edema due to retinal vein occlusion Retinal vein occlusion is a blockage of the small veins that carry blood away from the retina, which is that part of the eye that is responsible for vision. So, retinal vein occlusion often causes permanent damage to the retina and loss of vision. It can also lead to other eye problems. Sometimes there is a complete loss of vision almost immediately. Lucentis Injection helps treat swelling of the macula that can cause vision disturbances.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Lucentis Injection is an anti-angiogenic medication. It works by blocking a protein called vascular endothelial growth factor (VEGF). This stops the growth and leakage of abnormal blood vessels in the eye(s) that may cause vision loss.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Lucentis Injection . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Lucentis Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Lucentis Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Not Safe: Lucentis Injection may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Safe when prescribed by an expert: Lucentis Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Lucentis Injection may not be needed in these patients. Doctor consultation is advised.
Safe when prescribed by an expert: Lucentis Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Lucentis Injection may not be needed in these patients. Doctor consultation is advised.
If a dose of Lucentis Injection is missed, it's advisable to consult your doctor.
Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India
Henderer JD, Rapuano CJ. Ocular Pharmacology. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. p. 1794
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1196-97
Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 977
Drugs.com. Ranibizumab (04 Apr. 2019)
Ranibizumab. South San Francisco, California: Genentech, Inc.; 2006 (23 Jan. 2019)
Ranibizumab. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2007 (04 Apr. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.